CANF

Can-Fite Biopharma Ltd ADR

$0.66

-0 (-0.27%)

Analyst Overview

Target Price:

Date: 19.08.2025

$7.25

(+998.65%)

Strong Buy: 0

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. The company is headquartered in Petah-Tikva, Israel.

Exchange:

NYSE MKT

Country:

USA

Sector:

LIFE SCIENCES

Industry:

PHARMACEUTICAL PREPARATIONS

Address:

10 BAREKET STREET, KIRYAT MATALON, P.O. BOX 7537, PETACH TIKVA, IL

Fiscal year end:

December

Market capitalization:

$12.9 Million

EBITDA:

-$8.12 Million

PERatio:

0.0

EPS:

0.0

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.081

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

31-07-2015: $294.00 and 31-07-2025: $0.67